November 19, 2020
Imago BioSciences Raises $80 Million in Series C Financing
Imago BioSciences Raises $80 Million in Series C Financing
Updates &
Announcements
October 30, 2020
Atea Pharmaceuticals Announces Pricing of Initial Public Offering
Atea Pharmaceuticals Announces Pricing of Initial Public Offering
October 26, 2020
What can a biotech entrepreneur and a top scientist come up with on a couple of shared flights? Well… – Endpoints News
What can a biotech entrepreneur and a top scientist come up with on a couple of shared flights? Well… – Endpoints News
October 26, 2020
Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0
Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0
October 22, 2020
Replimune Announces Pricing of Upsized Public Offering
Replimune Announces Pricing of Upsized Public Offering
October 22, 2020
Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19
Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19
October 21, 2020
Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development
Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development
October 14, 2020
Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 14, 2020
Kronos Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Kronos Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 13, 2020
Chord Therapeutics launches with USD 16 million Series A financing from Omega Funds
Chord Therapeutics launches with USD 16 million Series A financing from Omega Funds
